Page 22 - Serum Institute Of India

Oxford vaccine: Serum to apply for emergency-use authorisation in 2 weeks

Serum Institute CEO Adar Poonawalla makes the announcement after a meeting with PM Narendra Modi, who was visiting key vaccine sites in India

Serum Institute to apply for emergency use of Covid vaccine in next 2 weeks

The company is the world's largest vaccine manufacturer.

Serum to submit data on two full doses of Covid-19 vaccine within deadline

Sources said the UK partner, AstraZeneca, would also submit the current data set to the regulator as planned, and provide additional test results, if sought

PM Modi's Serum visit shot in arm for India's Covid-19 vaccine image

Known for cranking out low-price vaccines, Serum Institute comes riding on the promise of a billion Covid shots

Covid updates on vaccine, lockdown chances and PM's Serum institute visit

Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year of Russia's Covid vaccine Sputnik V, in India

Covishield shows 60-70% efficacy; Modi to visit Serum Institute on Saturday

SII is unlikely to announce any interim data from the trials here. It will wait to compile and analyse data, before sharing it with the Indian regulator.

PM to visit Serum Institute in Pune on Nov 28 to review vaccine development

Rao had also informed that ambassadors and envoys from 100 countries will visit the Serum Institute of India and the Gennova Biopharmaceuticals Ltd here on December 4

PM Modi to visit Serum Institute of India in Pune on November 28

Serum Institute has partnered with global pharma giant AstraZeneca and the Oxford University

Envoys from 100 nations to visit Pune amid Covid vaccine production

Visit of the ambassadors was to take place on November 27, but it has now been rescheduled to December 4

Serum Institute to focus on supplying Oxford Covid vaccine to India first

Poonawalla said the company will be able to produce 400 million doses of AstraZeneca's vaccine by July 2021 and scale up further from there

Bill Gates, coronavirus and the initiative to vaccinate the world

If the initiative, aided by Mr. Gates's fortune and focus, manages to help protect the world's poor from a virus it will affirm the strategies he has promoted in his philanthropic work

Delighted at AstraZeneca vaccine's effectiveness: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Monday expressed happiness at pharma major AstraZeneca's announcement that its COVID-19 vaccine candidate has been found to be 70 per cent effective on average. AstraZeneca said one dosing regimen showed vaccine efficacy of 90 per cent when the vaccine was given as a half-dose followed by a full dose at least one month apart, while another dosing regimen showed 62 per cent efficacy when given as two full doses at least one month apart. "The combined analysis from both dosing regimens resulted in an average efficacy of 70 per cent," it added. In a tweet, Poonawalla said, "I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, #COVID19 vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime...". SII is currently conducting clinical trials of Oxford University-AstraZeneca's COVID-19 vaccine candidate in India. AstraZeneca also ...

Serum's Covid vaccine deadline, high-level teams sent to 4 states, & more

The vaccine developers are slowly, but surely are accepting the reality of not meeting the estimated targets in producing shots

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Top headlines: Govt expands stimulus, Moody's raises India GDP forecast

From govt announcing fresh stimulus aimed at creating jobs to TCS acquiring Pramerica Tech Services, Business Standard brings you the top headlines of the day

ICMR-Serum Institute Covid vaccine completes enrolment for phase 3 trials

ICMR and SII have further collaborated for the clinical development of COVOVAX (Novavax) developed by Novavax, USA and upscaled by SII

Govt may allow use of Covid vaccine in emergency situations: Harsh Vardhan

Warns of spike in cases during winter; China, UAE among the few countries have allowed such authorisation

Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline

Serum Institute to make 100 mn more doses of Covid vaccine for Rs 250 each

Secures additional $150 mn risk funding from Bill and Melinda Gates Foundation

Serum Institute to make an additional 100 million Covid-19 vaccine doses

BENGALURU (Reuters) - Serum Institute of India said on Tuesday it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses for India and other low- and middle-income countries next year.